CROI 2006: Index of Coverage

DO. SEE. HEAR. KNOW. Visit TheBody.com's 2008 World AIDS Day Center >>

Key Links:

By Topic:

Search:

Antiretrovirals in Development

HIV Antiretroviral Agents in Development (March 30, 2006)
An overview from Edwin DeJesus, M.D.
From The Body
Merck, Gilead Release Strong Findings From Clinical Trials of Experimental Integrase Inhibitor Antiretroviral Drugs (February 9, 2006)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation

Complications of HIV/HAART

Cardiovascular Risk and Antiretroviral Therapy: New Research on Epidemiology, Pathogenesis and Treatment (February 8, 2006)
In The 13th Conference on Retroviruses and Opportunistic Infections
Interventions for Fat Changes: New Research on Glitazones, Metformin and Testosterone (February 8, 2006)
In The 13th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
Link Between Tenofovir and Renal Toxicity Remains Tenuous, but Monitoring Is Warranted (February 8, 2006)
In The 13th Conference on Retroviruses and Opportunistic Infections
Studies Large and Small Investigate Predictors of HIV-Related Neurocognitive Problems (February 8, 2006)
In The 13th Conference on Retroviruses and Opportunistic Infections
Acid-Reducing Agents Reduce Atazanavir Drug Levels but Not Lopinavir/Ritonavir Levels (February 7, 2006)
In The 13th Conference on Retroviruses and Opportunistic Infections
Antiretroviral Exposure Not Associated With Liver-Related Deaths in D:A:D Cohort (February 7, 2006)
In The 13th Conference on Retroviruses and Opportunistic Infections
Incidence of AIDS-Associated and Non-AIDS-Associated Malignancies Among HIV-Infected Individuals (February 6, 2006)
Recent studies examine the risks for Kaposi's sarcoma, non-Hodgkin's lymphoma, cervical cancer, lung cancer and other malignancies.
In The 13th Conference on Retroviruses and Opportunistic Infections

Developing World

Type of AIDS Infection Key to Death Risk -- Study (February 13, 2006)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
In Uganda, Three-NRTI Regimen Including Abacavir Is Better Tolerated Than Nevirapine-Based Regimen (February 7, 2006)
In The 13th Conference on Retroviruses and Opportunistic Infections

Drug Resistance

More Sensitive Drug-Resistance Tests Yield Higher Rates of Multidrug Resistance in Treatment-Naive Patients (February 8, 2006)
In The 13th Conference on Retroviruses and Opportunistic Infections
Transmission of Multidrug-Resistant HIV Will Not Become More Frequent in United Kingdom Through 2010, Statistical Model Suggests (February 8, 2006)
In The 13th Conference on Retroviruses and Opportunistic Infections
Emtricitabine and Lamivudine May Be Similar, but Their Resistance Profiles Differ in Important Ways (February 6, 2006)
In The 13th Conference on Retroviruses and Opportunistic Infections

HIV Transmission

25 Years On, Scientists Still Struggling to Conquer AIDS (February 10, 2006)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
CROI 2006: Male Circumcision May Reduce Risk of HIV Transmission to Women (February 9, 2006)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Drug Combination Prevents HIV Infection in Monkeys (February 7, 2006)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Detecting Primary HIV Infection: Important for Prevention and, Extremely Rarely, Treatment as Well (February 7, 2006)
In The 13th Conference on Retroviruses and Opportunistic Infections

Treatment Strategies

Starting HIV-Positive Patients on HAART Early Reduces Treatment-Related Complications, Study Finds (February 9, 2006)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Debate Over Antiretroviral Treatment Interruption Remains After Findings Show Method Increases HIV-Positive Patients' Risk of AIDS, Death (February 8, 2006)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
New Developments on Therapeutic Vaccines and Immune-Based Therapies for HIV Infection (February 8, 2006)
In The 13th Conference on Retroviruses and Opportunistic Infections
Tipranavir Update at CROI 2006: RESIST Study Results, Drug Interactions and Therapeutic Drug Monitoring (February 8, 2006)
In The 13th Conference on Retroviruses and Opportunistic Infections
Pharmacokinetic Data Show That Fosamprenavir + Atazanavir Combination Should Not Be Used (February 6, 2006)
However, boosting with atazanavir instead of ritonavir does appear feasible, this study finds.
In The 13th Conference on Retroviruses and Opportunistic Infections

Women and Pregnancy

Nevirapine Reduces Risk of Mother-to-Child HIV Transmission in Repeat Pregnancies, Study Says (February 10, 2006)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
During the Third Trimester of Pregnancy Lopinavir/Ritonavir Dose Should Be Increased, Study Finds (February 6, 2006)
In The 13th Conference on Retroviruses and Opportunistic Infections
PI-Based Therapy Does Not Increase Glucose Intolerance, Gestational Diabetes in Pregnant, HIV-Infected Women (February 6, 2006)
In The 13th Conference on Retroviruses and Opportunistic Infections

The Body is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.